Agilent Technologies Inc
NYSE:A
Relative Value
The Relative Value of one
A
stock under the Base Case scenario is
142.99
USD.
Compared to the current market price of 125.52 USD,
Agilent Technologies Inc
is
Undervalued by 12%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
A Competitors Multiples
Agilent Technologies Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Agilent Technologies Inc
NYSE:A
|
35.6B USD | 5.1 | 27.3 | 19.9 | 23.6 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 393.7 | 4 661.3 | 1 477.8 | 3 157.4 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
189.6B USD | 4.3 | 28.3 | 19.8 | 26.6 | |
| US |
|
Danaher Corp
NYSE:DHR
|
149.1B USD | 6.1 | 41.3 | 22.8 | 34.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
46.3T KRW | 8.4 | 29 | 16.9 | 22.5 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.6B CHF | 5.5 | 37.9 | 27.8 | 27.8 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
292.3B CNY | 6.6 | 19.5 | 19.7 | 19.7 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.4B USD | 1.7 | 20.7 | 11.6 | 17.4 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.9B USD | 6.9 | 32 | 23.6 | 26.3 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
163.2B HKD | 7.2 | 34.3 | 24.1 | 24.1 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
17B EUR | 6 | 66.8 | 23.2 | 38.2 |